Anika Therapeutics shares owned by AQR Capital Management
Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by AQR Capital Management
from 13F filings
Historical chart of AQR Capital Management investment in Anika Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Anika Therapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Anika Therapeutics by AQR Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $767k | 31k | 25.00 |
2024-06-30 | $2.7M | 107k | 25.33 |
2024-03-31 | $2.5M | 99k | 25.40 |
2023-12-31 | $2.1M | 94k | 22.66 |
2023-09-30 | $1.4M | 74k | 18.63 |
2023-06-30 | $833k | 32k | 25.98 |
2023-03-31 | $914k | 32k | 28.72 |
2022-12-31 | $943k | 32k | 29.60 |
2022-09-30 | $580k | 24k | 23.78 |
2022-06-30 | $328k | 15k | 22.31 |
2020-09-30 | $1.9M | 54k | 35.39 |
2020-06-30 | $4.4M | 118k | 37.73 |
2020-03-31 | $3.5M | 121k | 28.91 |
2019-12-31 | $4.7M | 90k | 51.85 |
2019-09-30 | $1.9M | 35k | 54.90 |
2019-06-30 | $244k | 6.0k | 40.58 |
2019-03-31 | $480k | 16k | 30.22 |
2018-12-31 | $508k | 15k | 33.63 |
2018-09-30 | $932k | 29k | 32.00 |
2018-06-30 | $932k | 29k | 32.00 |
2018-03-31 | $2.2M | 43k | 49.73 |
2017-12-31 | $2.3M | 43k | 53.92 |
2017-09-30 | $2.7M | 47k | 58.00 |
2017-06-30 | $2.6M | 53k | 49.35 |
2017-03-31 | $2.7M | 62k | 43.44 |
2016-12-31 | $5.6M | 114k | 48.96 |
2016-09-30 | $7.1M | 148k | 47.85 |
2016-06-30 | $5.6M | 105k | 53.65 |
2016-03-31 | $2.6M | 59k | 44.72 |
2015-12-31 | $3.9M | 103k | 38.15 |
2015-09-30 | $3.8M | 121k | 31.82 |
2015-06-30 | $6.1M | 184k | 33.03 |
2015-03-31 | $8.3M | 202k | 41.17 |
2014-12-31 | $9.1M | 224k | 40.74 |
2014-09-30 | $5.9M | 162k | 36.66 |
2014-06-30 | $2.1M | 46k | 46.34 |
2014-03-31 | $1.7M | 42k | 41.10 |
2013-12-31 | $356k | 9.3k | 38.19 |
More positions owned by AQR Capital Management
Cigna Corp (CI)
View all positions for AQR Capital Management